aterial thrombosis
venous thrombosis
what’s added to tube when measuring coagulation factors to stop clotting
citrate
what does PT measure
time taken to clot in extrinsic and common pathways
what does APTT measure
time taken to clot in intrinsic and common pathways
what does INR measure
ratio of normal PT compared to patient PT therefore ideal INR is ~1.
only technically valid for warfarin.
what triggers intrinsic pathway
contact factor
what triggers extrinsic pathway
tissue factor
what is a DOAC
direct acting oral anticoagulant
which DOACs inhibit factor X
rivaroXaban, edoXaban, apiXaban
which DOAC inhibits factor II
Dabigatran (anti-thrombin)
How do DOACs affect coag panel tests
variable non-linear impact on PT and APTT
what are DOACs used for
stroke prevention, DVT, pulmonary embolism
what cofactor does synthesis of IX, X, II, and VII require
vitamin K
what is warfarin
a vitamin K antagonist therefore anticoagulant
what coag panel tests does warfarin affect
prolongs PT and APTT
PT is particularly sensitive to it.
INR used to adjust dose
what are heparins
sulphated glycosaminoglycans.
how do heparins inhibit coagulation
how is unfractionated heparin delivered
intravenously with loading dose before continuous infusion.
needs careful monitoring
binds to antithrombin and thrombin
how is low molecular weight heparin delivered
subcut injection
only binds to antithrombin which acts on factor Xa
how does heparin affect coag panel test
affects APTT
what do thrombolytic drugs target
plasminogen e.g. tPA
primary prevention using anti platelets
if high cardiovascular risk score
secondary prevention using anti platelets
after MI, stroke, stent, PVD